Business and Economy

Most viewed

TECNO LAUNCHES CAMON 20 SERIES WITH FLAGSHIP AESTHETIC DESIGN IN GHANA

TECNO, one of the most preferred smartphone brands on the Ghanaian market and a major player worldwide, has launched its newest CAMON. This spectacular event

3 years ago by Geraldo Amartey

Fuel prices set to increase from July 16, COPEC shares projections
Fuel prices to go down effective January 17, COPEC sites international market trends
$5G internet in Ghana: Reason NCA removed Next Gen Infraco’s exclusive wholesale 5G rights$
5G internet in Ghana: Reason NCA removed Next Gen Infraco’s exclusive wholesale 5G rights
Cedi maintains position among strongest currencies in Africa heading into July, beats South Africa and co
Roofs coated with canopy-like solar panels and indoor spaces awash in sunglight: Google has bet big on in-person work with its sprawling new Silicon Valley offices.

Business and Economy Latest News

'Weak tea': Climate scientists push back against COP28 cheer

2 years ago by AFP

Brazil cuts interest rate another half-point

2 years ago by AFP

'We have to endure' - Argentines stoic as prices skyrocket

2 years ago by AFP

TCL Launches its New C645 QLED TVs For Exceptional Colour Performance and Endless Entertainment

2 years ago by Jeffrey Owusu-Mensah

Thanks to state-of-the-art Quantum Dot Technology, the TCL C645 delivers genuine cinematic colours made from over a billion different colours and shades.

BP sacks former CEO for 'serious misconduct'

2 years ago by AFP

BP on Wednesday denied its former chief executive of more than £32-million ($40-million) payout because of his failure to disclose past personal relationships with colleagues. A year earlier, Brian Krzanich stepped down as chief executive of US computer chip giant Intel over a "past consensual relationship" with an employee in violation of the company's non-fraternisation policy. phz/srg/cw

Pfizer shares tumble on disappointing 2024 profit outlook

2 years ago by AFP

Pfizer issued a disappointing 2024 forecast Wednesday, denting shares as the company navigates a profound plunge in sales tied to the Covid-19 pandemic. The company, which reported more than $100 billion in revenue in 2022 due to the lift from Covid-19 vaccine and therapeutic sales, sees 2024 revenues of between $58.5 billion and $61.5 billion, according to its presentation.

Business and Economy